These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11340076)

  • 1. Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells.
    Möller T; Contos JJ; Musante DB; Chun J; Ransom BR
    J Biol Chem; 2001 Jul; 276(28):25946-52. PubMed ID: 11340076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
    Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
    J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern.
    Contos JJ; Chun J
    Gene; 2001 Apr; 267(2):243-53. PubMed ID: 11313151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.
    Ishii I; Contos JJ; Fukushima N; Chun J
    Mol Pharmacol; 2000 Nov; 58(5):895-902. PubMed ID: 11040035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).
    Contos JJ; Ishii I; Fukushima N; Kingsbury MA; Ye X; Kawamura S; Brown JH; Chun J
    Mol Cell Biol; 2002 Oct; 22(19):6921-9. PubMed ID: 12215548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.
    Hama K; Bandoh K; Kakehi Y; Aoki J; Arai H
    FEBS Lett; 2002 Jul; 523(1-3):187-92. PubMed ID: 12123830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.
    An S; Bleu T; Zheng Y; Goetzl EJ
    Mol Pharmacol; 1998 Nov; 54(5):881-8. PubMed ID: 9804623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid receptor signaling in mammalian retinal pigment epithelial cells.
    Thoreson WB; Ryan JS; Shi C; Kelly ME; Bryson EJ; Toews ML; Ediger TL; Chacko DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2450-61. PubMed ID: 12091450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lysophosphatidic acid receptor-stimulated response by G-protein-coupled receptor kinase-2 and beta-arrestin1 in FRTL-5 rat thyroid cells.
    Iacovelli L; Capobianco L; D'Ancona GM; Picascia A; De Blasi A
    J Endocrinol; 2002 Jul; 174(1):103-10. PubMed ID: 12098668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid receptors.
    Contos JJ; Ishii I; Chun J
    Mol Pharmacol; 2000 Dec; 58(6):1188-96. PubMed ID: 11093753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel Xenopus homologs of mammalian LP(A1)/EDG-2 function as lysophosphatidic acid receptors in Xenopus oocytes and mammalian cells.
    Kimura Y; Schmitt A; Fukushima N; Ishii I; Kimura H; Nebreda AR; Chun J
    J Biol Chem; 2001 May; 276(18):15208-15. PubMed ID: 11278944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer.
    Schulte KM; Beyer A; Köhrer K; Oberhäuser S; Röher HD
    Int J Cancer; 2001 Apr; 92(2):249-56. PubMed ID: 11291053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
    Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
    FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.
    An S; Bleu T; Hallmark OG; Goetzl EJ
    J Biol Chem; 1998 Apr; 273(14):7906-10. PubMed ID: 9525886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
    Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
    J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling.
    Weiner JA; Fukushima N; Contos JJ; Scherer SS; Chun J
    J Neurosci; 2001 Sep; 21(18):7069-78. PubMed ID: 11549717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
    Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
    Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native and recombinant human Edg4 receptor-mediated Ca(2+) signalling.
    Simpson PB; Villullas IR; Schurov I; Kerby J; Millard R; Haldon C; Beer MS; McAllister G
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):31-40. PubMed ID: 15090154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
    Fischer DJ; Liliom K; Guo Z; Nusser N; Virág T; Murakami-Murofushi K; Kobayashi S; Erickson JR; Sun G; Miller DD; Tigyi G
    Mol Pharmacol; 1998 Dec; 54(6):979-88. PubMed ID: 9855625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.